Active Ingredient(s): Rituximab-abbs
FDA Approved: * November 28, 2018
Pharm Company: * CELLTRION INC
Category: Cancer

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Truxima Overview

Rituximab, sold under the brand name Rituxan, is a medication used to treat certain autoimmune diseases and types of cancer.[8] It is used for non-Hodgkin lymphoma, chronic lymphocytic leukemia(in non-geriatric patients), rheumatoid arthritis, granulomatosis with polyangiitis, idiopathic thrombocytopenic purpura, pemphigus vulgaris, myasthenia gravis and Epstein–Barr virus-positive mucocutaneous ulcers.[8][9][10][11...

Read more Truxima Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Truxima Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

  • Injection: 100mg, 100mg/10ml(10mg/ml), 10mg/ml, 500mg, 500mg/50ml(10mg/ml)
  • Solution: 100mg/10ml (10mg/ml), 500mg/50ml (10mg/ml)
  • Vial: 10mg/ml
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Truxima: (2 results)

Sorted by National Drug Code
  • 63459-103 Truxima 10 mg/ml Intravenous Injection, Solution by Cephalon, Inc.
  • 63459-104 Truxima 10 mg/ml Intravenous Injection, Solution by Cephalon, Inc.

Other drugs which contain Rituximab-abbs or a similar ingredient: (7 results)